ARCT Stock Price
ARCT
ARCT stock price is $10.87 (+13.94% on the day), giving ARCT a market cap of $271.16M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
ARCT Stock Overview
- Price
- $10.87
- Previous close
- $9.54
- Open
- $9.89
- Market cap
- $271.16M
- 1-year price target
- $22.00
- MarketXLS Rank
- 40
About ARCT
Arcturus Therapeutics Holdings Inc. engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms includes LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate that is in phase 2 clinical trial for cystic fibrosis. Its product pipeline includes KOSTAIVE for the treatment of covid 19; ARCT-2138 (LUNAR-FLU), which is in phase 1 clinical trial for the treatment of seasonal influenza; ARCT-2304 (LUNAR-H5N1) that is in phase 1 clinical trial for the treatment of Pandemic Influenza; ARCT-2301 for bivalent: ancestral/omicron which is in Phase 3 clinical trial; and ARCT-2303 for monovalent that is in Phase 3 clinical trial. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ARCT | $10.87 | +13.9% | 495.81K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |